Diagnosis and Treatment of Pulmonary Embolism During the Coronavirus Disease 2019 Pandemic

[1]  D. Leaf,et al.  COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection , 2020, Blood.

[2]  O. Pajot,et al.  Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study , 2020, Critical Care.

[3]  P. Wells,et al.  Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019 , 2020, Chest.

[4]  R. V. Vander Heide,et al.  Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans , 2020, The Lancet Respiratory Medicine.

[5]  Axel Haverich,et al.  Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. , 2020, The New England journal of medicine.

[6]  Arthur L. Allen,et al.  Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum , 2020, Journal of Thrombosis and Thrombolysis.

[7]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[8]  D. Gommers,et al.  Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis , 2020, Thrombosis Research.

[9]  S. Susen,et al.  Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence. , 2020, Circulation.

[10]  Yaolong Chen,et al.  Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines , 2020, Thrombosis and Haemostasis.

[11]  L. Beenen,et al.  Incidence of venous thromboembolism in hospitalized patients with COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[12]  Nathaniel Hupert,et al.  Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.

[13]  Yutao Guo,et al.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up , 2020, Journal of the American College of Cardiology.

[14]  J. Q. Brown,et al.  Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans , 2020, medRxiv.

[15]  D. Gommers,et al.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19 , 2020, Thrombosis Research.

[16]  W. Liang,et al.  Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19 , 2020, The Lancet Haematology.

[17]  Feng Wang,et al.  Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[18]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[19]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[20]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[21]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[22]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[23]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[24]  J. Bartholomew,et al.  Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes. , 2019, The American journal of cardiology.

[25]  Ayman Elbadawi,et al.  The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department , 2019, Journal of Thrombosis and Thrombolysis.

[26]  Michael C. McDaniel,et al.  Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium , 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[27]  R. Rosovsky,et al.  Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions , 2019, Research and practice in thrombosis and haemostasis.

[28]  S. Smyth,et al.  The implementation of a pulmonary embolism response team in the management of intermediate- or high-risk pulmonary embolism. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[29]  T. Sundt,et al.  Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis , 2018, Journal of Thrombosis and Thrombolysis.

[30]  R. Rosovsky,et al.  Pulmonary Embolism Response Team: Inpatient Structure, Outpatient Follow-up, and Is It the Current Standard of Care? , 2018, Clinics in chest medicine.

[31]  A. Singer,et al.  Emergency Department Discharge of Pulmonary Embolus Patients , 2018, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[32]  J. Giri,et al.  Treatment of submassive and massive pulmonary embolism: a clinical practice survey from the second annual meeting of the Pulmonary Embolism Response Team Consortium , 2018, Journal of Thrombosis and Thrombolysis.

[33]  C. Baugh,et al.  The creation and implementation of an outpatient pulmonary embolism treatment protocol , 2017, Hospital practice.

[34]  J. Giri,et al.  Nuts and bolts of running a pulmonary embolism response team: results from an organizational survey of the National PERT™ Consortium members , 2017, Hospital practice.

[35]  J. Giri,et al.  Diversity in the Pulmonary Embolism Response Team Model: An Organizational Survey of the National PERT Consortium Members. , 2016, Chest.

[36]  B. Parry,et al.  The Outpatient Treatment of Venous Thromboembolism: Operational Impact and the Role of Novel Anticoagulants , 2016, Seminars in Thrombosis and Hemostasis.

[37]  Elie A Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[38]  Austin Johnson.  Outpatient versus Inpatient Treatment for Patients with Acute Pulmonary Embolism: An International, Open-label, Randomised, Non-inferiority Trial , 2011 .

[39]  Nathan A. Pugh,et al.  Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial , 2011, The Lancet.

[40]  H. Büller,et al.  Outpatient treatment of patients with pulmonary embolism. , 2001, Seminars in vascular medicine.